Tumor necrosis factor ~ (TNFet) orchestrates a wide range of effects that combat severe infections in animals. At lower levels, TNF,, plays an important protective role in stimulating chemotaxis and antimicrobial activity of neutrophils, macrophages, and eosinophils. During chronic illness, TNFet secretion can be elevated markedly, giving rise to cachexia, hemorrhage, necrosis and, ultimately, death. Although TNFct may mediate many of its effects through macrophages, 30% of TNFct injected into animals concentrates in the skin. In recent years, it has been shown that keratinocytes can be induced to synthesize TNF~. To explore the role of TNF~ synthesis in keratinocytes, we used a keratin-14 (K14) promoter to target human TNF~ expression in the epidermis and other stratified squamous epithelia of transgenic mice. Most mice expressing the K14-TNF,v transgene stopped gaining weight within 1 week postbirth, and exhibited retarded hair growth. In the skin, adipose production was profoundly inhibited, whereas signs of fibrosis and immune infiltration were evident in the dermis. Over time, the epidermis exhibited an increased stratum corneum, as signs of necrosis began to appear in the skin. Within 3-5 weeks, the mice displayed features characteristic of cachexia and necrosis. Our results suggest that TNF~ expression by keratinocytes not only plays a role in inflammatory and graft-versus-host-disease-like responses in the skin, but also in other tissues, apparently by virtue of stratified squamous epithelial-derived TNFoL entering the bloodstream. Our results have enabled the first evaluation of many of the effects of TNF~ in transgenic animals.